HF
IMNM icon

HRT Financial’s Immunome IMNM Stock Holding History

HRT Financial’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-69,305
Closed -$1.71M – 2614
2024
Q1 		$1.71M Buy
+69,305
New +$1.41M 0.01% 640

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

HRT Financial's IMNM Position: Q2 2024 in Review

HRT Financial sold out of Immunome (IMNM) in Q2 2024, closing a stake of 69,305 shares — an estimated $1.71M sold.

HRT Financial first reported a position in IMNM in Q1 2024 and held it in 1 quarter. The position peaked at $1.71M in Q1 2024. 113 funds tracked by Wall St. Rank hold IMNM as of Q2 2024.

  • HRT Financial reported no remaining Immunome position as of Q2 2024 after selling out during the quarter.
  • HRT Financial sold 69,305 Immunome shares in Q2 2024, an estimated $1.71M.
  • HRT Financial first reported a position in Immunome in Q1 2024 and held it in 1 quarter.
  • HRT Financial's Immunome position peaked at $1.71M in Q1 2024.
  • 113 funds tracked by Wall St. Rank held Immunome as of Q2 2024.

Based on HRT Financial's 13F filing for Q2 2024, filed 12 Aug 2024.